Key points are not available for this paper at this time.
The landscape of cervical cancer in Australia has evolved considerably over recent decades. Implementation of the national HPV Vaccination Program and National Cervical Screening Program (NCSP) has driven sustained declines in incidence and mortality, making elimination as a public health problem potentially achievable within the next decade. Concurrent advances in surgical techniques, radiotherapy delivery and systemic therapies have improved treatment efficacy and safety, resulting in incremental gains in disease control and survival. Australian researchers have contributed significantly to this progress, and clinical outcomes reported in local institutional series and population-based analyses are consistently comparable to international benchmarks. Nevertheless, several challenges remain. These include sustaining brachytherapy expertise amid falling case volumes, addressing inequities in access, and integrating emerging systemic agents. These and other issues will demand continued engagement and coordination among clinicians, policymakers and stakeholders. This review outlines the principal developments that have shaped contemporary cervical cancer care in Australia, summarises current practice, and identifies key challenges and future directions for the field.
Mills et al. (Tue,) studied this question.